Patent · US Active

Protein antigens for vaccinating against nontypeable Haemophilus influenzae

US11357845B2 · kind B2 · utility

0Cited by
1References
51Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 7, 2020
Grant dateJun 14, 2022
Priority date
Expiry dateJul 7, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/57
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes methods for treating and/or immunizing against Haemophilus influenzae, including nontypeable H. influenzae (NTHi). The methods comprise administering a composition comprising H. influenzae proteins OppA and/or LapB.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.